Bruno Guy

This inventor holds 16 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Sanofi Pasteur Inc., Centers for Disease Control and Prevention, Sanofi Pasteur Sa. Active years: 2000-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruno Guy. Retrieved from https://idiyas.com/inventor/bruno-guy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 7)

% Patents Active = 62.5

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 95(Granted Patents)

Company Filing History:

Centers for Disease Control and Prevention

Connaught Laboratories Limited

patents

5. 2 out of 4

Center for Disease Control and Prevention

Pasteur Merieux Serums & Vaccins

patents

8. 2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2018

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9937252 - Induction of cross-reactive cellular response against rhinovirus antigens (2018-04-10),

2. 9169298 - Dengue serotype 1 attenuated strain (2015-10-27),

3. 8795688 - Dengue serotype 2 attenuated strain (2014-08-05),

4. 8506971 - Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria (2013-08-13),

5. 8067566 - Dengue serotype 2 attenuated strain (2011-11-29),

6. 8067565 - Dengue serotype 1 attenuated strain (2011-11-29),

7. 7718359 - Method of immunization against the 4 serotypes of dengue fever (2010-05-18),

8. 7718358 - Method of immunization against the 4 dengue serotypes (2010-05-18),

9. 7718357 - Method of immunization against the 4 dengue serotypes (2010-05-18),

10. 7641908 - Dengue serotype 2 attenuated strain (2010-01-05),

11. 7641907 - Dengue serotype 1 attenuated strain (2010-01-05),

12. 7235243 - Immunological combination compositions and methods (2007-06-26),

13. 6984385 - Immunological combination compositions and methods (2006-01-10),

14. 6576244 - LT and CT in parenteral immunization methods against helicobacter infection (2003-06-10),

15. 6379675 - Immunological combination compositions and methods (2002-04-30),

Title: The Innovative Contributions of Bruno Guy

Introduction

Bruno Guy is a prominent inventor based in Lyons, France, known for his significant contributions to the field of biomedical research. With a total of 16 patents to his name, he has made remarkable advancements in the understanding and treatment of viral infections.

Latest Patents

Among his latest patents is the invention concerning the induction of cross-reactive cellular response against rhinovirus antigens. This invention involves an isolated peptide that is at least 90% identical to the VP4 amino acid sequence of a rhinovirus, along with an isolated polynucleotide encoding said peptide. Additionally, he has developed a vaccine composition that includes a live attenuated strain of Dengue serotype 1, derived from the wild-type dengue-1 strain 16007. This innovative approach aims to enhance the efficacy of vaccines against these viral infections.

Career Highlights

Bruno Guy has had a distinguished career, working with notable companies such as Sanofi Pasteur Inc. and Sanofi Pasteur S.A. His work has been instrumental in advancing vaccine development and improving public health outcomes.

Collaborations

Throughout his career, Bruno has collaborated with esteemed colleagues, including Jean Lang and Véronique Barban. These partnerships have fostered a collaborative environment that has led to groundbreaking research and innovations.

Conclusion

Bruno Guy's contributions to the field of biomedical research and his innovative patents highlight his role as a leading inventor in the industry. His work continues to impact the development of effective treatments and vaccines for viral infections.

Profile summary based on public USPTO records.